Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Bimagrumab: Reducing fat and retaining muscle Bimagrumab, a drug developed by Eli Lilly, aims to help those taking it reduce fat whilst retaining muscle
Its primary biological role is acting as a transport molecule carrying long-chain fatty acids across the inner mitochondrial membrane where they are oxidised ("burned") to produce ATP energy
For individuals taking glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), or the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), maintaining adequate magnesium status may be particularly important
Everything else derives from it
Both blends are independently lab-tested by Freedom Diagnostics Lab and verified at 99%+ purity by HPLC
insert the needle at 4590 into subcutaneous tissue [13]
